Mylan To Disallow Wholesaler Investment Buying Ahead Of Price Increases
Mylan will no longer allow wholesalers to investment buy ahead of price increases, CEO Milan Puskar said during a June 8 conference call.
You may also be interested in...
Watson expects its generic drug business to top $800 mil. in revenues during 2001 after it completes the proposed acquisition of Schein.
Mylan has increased the price of its generic version of lorazepam more than threefold. On March 3, the price for a bottle of 100 lorazepam 5 mg tablets increased from $16.95 to $64.31.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011